Navigation Links
AVT Developed and Integrated System Featured on KTLA News

HOLLYWOOD, Calif., Jan. 17, 2012 /PRNewswire/ -- AVT, Inc. (Ticker: AVTC) ( had had one of their automated systems featured on KTLA News in a segment discussing the future of prescription medicine dispensing.

The AVT developed Medbox™ Rx Prescription Dispensing System was on display, and a company spokesperson described how the process works.

The story stated that when a customer drops off their prescription at the pharmacy, the pharmacist will ask if they want to pick up their medicine at the counter or at the automated, self-serve system. If the customer opts to pick up their prescription at their convenience from the Medbox™ Rx system, the pharmacist will place the medicine in one of 200 individual lock boxes. The customer will access the lock box by swiping their special identification card and passing a fingerprint recognition scan.

AVT developed the system in partnership with Medbox, and it is the world's first medical dispensing system to feature a patented biometric fingerprint recognition program, which assures patient identity and provides military grade security. The system also takes a photograph of each person conducting a transaction, and provides an unalterable record of every operation.

AVT is also developing other automated retailing systems that use biometric security systems to increase safety, enhance consumer and merchant confidence, and reduce fraud.

To view the KTLA News Story, please visit:

For more information on AVT, please call 877.424.3663 or visit the website at

About AVT:

AVT, Inc. is a leading developer of automated and self-service retailing systems. AVT is able to work with any size company to design a custom automated retailing solution that drives traffic, increases sales, improves security, and lowers overhead. With an in-house design team, software developers, mechanical engineers and on-site manufacturing, AVT can take projects from concept to completion with speed, economy and ingenuity.

AVT's stock is traded through the OTC Markets, Ticker Symbol: AVTC:PK

For more information on AVT or the Automated Retailing Industry, visit

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
2. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
3. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
4. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
5. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
6. More Than 300 New Medicines Being Developed for Mental Illnesses
7. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
8. Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists
9. DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers
10. deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimers and Other Cognitive Disorders
11. Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
Post Your Comments:
(Date:11/29/2015)... Nov. 29, 2015  The GE Health Cloud 1 ... Society of North America (RSNA) meeting ... healthcare industry, the new cloud ecosystem and its applications will ... care pathways and multidisciplinary teams – both inside and outside ... and CEO of GE. "As the digital industrial leader, we ...
(Date:11/27/2015)... , Pays-Bas, November 27, 2015 ... au traitement photodynamique au Bremachlorin contre le cancer ... approche consistant à combiner l,immunothérapie au traitement photodynamique ... --> Une nouvelle approche consistant ... contre le cancer avancé.    ...
(Date:11/27/2015)... 27, 2015  Lannett Company, Inc. (NYSE: ... the acquisition of Kremers Urban Pharmaceuticals Inc. (KU), ... biopharmaceuticals company UCB S.A. (Euronext: UCB). ... acquired KU from UCB for total consideration of ... a customary working capital adjustment, a deduction of ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... ... There is only one major question facing all law firms in the 21st ... not been an easy question to answer. Especially when the senior partners and lawyers ... share the same discipline around working long hours. , In addition to this ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... According to ... out by the University of Toronto and the University of British Columbia suggested that ... for head injuries. The article explains that part of the reason for the controversial ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the health care in America. As people age, more care is needed, especially ... are rising, and medical professionals are being overworked. The forgotten part of this ...
(Date:11/27/2015)... PA (PRWEB) , ... November 27, 2015 , ... ... be a safe and convenient way to dispense prescription medications at home, so ... and effective way to monitor and dispense prescription medications. In doing so, it ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a special ... 10% off of their purchase of lice treatment product. In addition, customers will receive ... a company spokesperson. “Finding lice is a sure way to ruin the holidays, so ...
Breaking Medicine News(10 mins):